We are live on ! Find out more
CVS icon

CVS Health

1,555 hedge funds and large institutions have $90B invested in CVS Health in 2015 Q4 according to their latest regulatory filings, with 154 funds opening new positions, 707 increasing their positions, 568 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more first-time investments, than exits

New positions opened: 154 | Existing positions closed: 94

24% more repeat investments, than reductions

Existing positions increased: 707 | Existing positions reduced: 568

3% more funds holding

Funds holding: 1,5121,555 (+43)

8% more call options, than puts

Call options by funds: $595M | Put options by funds: $550M

0% more capital invested

Capital invested by funds: $89.7B → $90B (+$208M)

0.48% less ownership

Funds ownership: 83.98%83.5% (-0.48%)

10% less funds holding in top 10

Funds holding in top 10: 223200 (-23)

Holders
1,555
Holders Change
+43
Holders Change %
+2.84%
% of All Funds
40.78%
Holding in Top 10
200
Holding in Top 10 Change
-23
Holding in Top 10 Change %
-10.31%
% of All Funds
5.25%
New
154
Increased
707
Reduced
568
Closed
94
Calls
$595M
Puts
$550M
Net Calls
+$45.1M
Net Calls Change
+$123M
Name Holding Trade Value Shares
Change
Change in
Stake
ECM
876
Evergreen Capital Management
Washington
$2.34M -$61.4K -627 -3%
BCA
877
Bray Capital Advisors
Florida
$2.33M +$273K +2,785 +13%
VFA
878
Voya Financial Advisors
Connecticut
$2.33M +$264K +2,698 +13%
SSIA
879
Spero-Smith Investment Advisers
Ohio
$2.33M -$47.9K -489 -2%
TI
880
TT International
United Kingdom
$2.32M +$594K +6,069 +34%
NPC
881
National Planning Corporation
California
$2.31M +$136K +1,387 +6%
Kayne Anderson Rudnick Investment Management
882
Kayne Anderson Rudnick Investment Management
California
$2.31M +$1.4M +14,246 +151%
PJSIMP
883
P.J. Schmidt Investment Management (PJS)
Wisconsin
$2.3M +$513K +5,242 +29%
DRD
884
Dennis R. Delaney
$2.3M +$2.3M +23,532 New
AssetMark Inc
885
AssetMark Inc
California
$2.3M +$1.17M +11,920 +103%
CSS
886
Cubist Systematic Strategies
Connecticut
$2.3M -$4.63M -47,260 -67%
NIS
887
National Investment Services
Wisconsin
$2.29M -$54.6K -558 -2%
ECM
888
Element Capital Management
New York
$2.29M +$134K +1,373 +6%
NAM
889
North American Management
Massachusetts
$2.28M +$37.2K +380 +2%
MYAM
890
Meiji Yasuda Asset Management
Japan
$2.28M -$59.7K -610 -3%
1GA
891
1st Global Advisors
Texas
$2.27M +$89.6K +915 +4%
CIM
892
Cambria Investment Management
California
$2.26M -$147K -1,498 -6%
JFGIW
893
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$2.26M +$891K +9,100 +65%
TBA
894
Train Babcock Advisors
New York
$2.26M -$29.9K -305 -1%
PP
895
Pegasus Partners
Wisconsin
$2.25M -$32.3K -330 -1%
DIA
896
Denver Investment Advisors
Colorado
$2.23M -$1.3M -13,240 -37%
TRIM
897
Thompson Rubinstein Investment Management
Oregon
$2.23M
NED
898
Nancy E. Dempze
$2.22M +$2.22M +22,715 New
CIP
899
Capital Insight Partners
Arizona
$2.21M +$2.21M +22,595 New
NI
900
Numeric Investors
Massachusetts
$2.18M -$68.7M -701,200 -97%

CVS Hedge Fund Activity: Q4 2015 in Review

1,555 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q4 2015, worth a combined $90B — up 0.23% from $89.7B a quarter earlier.

Buyers outnumbered sellers: 154 funds opened new CVS positions and 94 closed out — a net gain of 60 holders — while 707 added to existing stakes and 568 trimmed.

The largest buyer was Magellan Asset Management, opening a new position worth an estimated $966M. The largest seller was Fidelity Investments, cutting an estimated $976M.

  • 1,555 institutional investors held CVS Health (CVS) as of Q4 2015, up from 1,512 in Q3 2015.
  • Funds reported $90B of CVS Health stock for Q4 2015, up 0.23% quarter-over-quarter.
  • 154 funds opened new CVS Health positions in Q4 2015 and 94 closed out, a net change of +60 holders.
  • The largest CVS Health buyer in Q4 2015 was Magellan Asset Management, an estimated $966M added.
  • The largest CVS Health seller in Q4 2015 was Fidelity Investments, an estimated $976M sold.

Based on aggregated 13F filings for Q4 2015.